Rocket Lab (RKLB) has pulled back to $56.67 after a volatile stretch, following a post-earnings surge that had lifted the shares sharply earlier in the week. The latest company release showed recor...
Rocket Lab (RKLB) was trading at $56.67, down 3.95% over 24 hours, after ranging between $61.99 and $56.13. The move comes after a strong reaction to the company’s November 9 third-quarter results, which highlighted record revenue, $1.2 billion of backlog and positive GAAP operating cash flow. That mix matters because it shows the market is still willing to reward execution, even as the shares digest the recent spike.
The stock’s earlier move was powerful. TipRanks said RKLB had gained nearly 7% on November 11 and was up 44% over four days, following the earnings release. That kind of swing usually leaves the tape vulnerable to consolidation, and that is what the current price action is showing.
Rocket Lab’s November 9 release was the core fundamental driver. The company said third-quarter 2026 revenue reached a record level, backlog increased 52% sequentially to $1.2 billion, and it generated positive GAAP operating cash flow. It also guided to record revenue and gross margin expansion in the fourth quarter of 2026.
Analyst commentary has leaned constructive on that backdrop. Morgan Stanley kept an Overweight rating and set a $103 target. TipRanks reported that the firm sees more upside ahead, while Berenberg lifted its target to $85 from $83 and kept a Buy rating, citing launch demand, Neutron already sold into the 2030s, and an existing-business adjusted EBITDA margin of about 10% excluding roughly $45 million per quarter of Neutron R&D.
Source link







